Ascend Minocycline Tablets Recall: Failed Dissolution Test Risk
Ascend Laboratories recalls 115mg Minocycline Hydrochloride Extended-Release Tablets due to failed dissolution test. This may affect medication effectiveness. Check NDC 67877-644-30 and lot numbers for affected products.
Lower-risk recall
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Contact the company
What happened, in plain English
Ascend Laboratories is recalling 115mg Minocycline Hydrochloride Extended-Release Tablets because they failed a dissolution test. This could mean the medication doesn't work as intended. People with prescriptions for this product should check their NDC number and lot date. Read more at govinfonow.com/recall/31245-ascend-minocycline-tablets-recall-failed-dissolution-test-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31245-ascend-minocycline-tablets-recall-failed-dissolution-test-risk · Updated August 10, 2026 · FDA enforcement record: FDA #D-0597-2026
Cite this page
“Ascend Minocycline Tablets Recall: Failed Dissolution Test Risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31245-ascend-minocycline-tablets-recall-failed-dissolution-test-risk. Based on FDA recall #D-0597-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0597-2026%22&limit=1).
Why it’s dangerous
The tablets failed a dissolution test during the 9th month of analysis. This suggests the medication may not release properly in the body, potentially reducing effectiveness. However, the recall does not indicate immediate harm or injury.
Who’s affected
Prescription holders of the 115mg Minocycline Hydrochloride Extended-Release Tablets with NDC 67877-644-30. Patients who have been prescribed this medication are most at risk.
How to tell if you have this one
Check for the NDC number 67877-644-30 and lot number 25141635 on the bottle. The product is a prescription-only 115mg tablet with 30 tablets per bottle.
- Brand
Ascend Laboratories- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 67877-644-30 and lot number 25141635 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 16 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have this product?
Check the NDC number and lot number on the bottle. If it matches the recalled product, contact your doctor for alternative medication.
Similar recalls
Other Ascend Laboratories recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0597-2026 (June 1, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0597-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.